Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Treating endothelial cells obtained from scleroderma patients with an enzyme called khloto effectively improves their function, according to a study published in the journal Arthritis Research and Therapy.
Frequent cough, which commonly occurs in lung disease related to scleroderma correlates both with the presence and severity of gastroesophageal reflux disease (GERD – a chronic digestive disease where ... Read more
Treating patients with drug resistant progressive scleroderma with a combination of immunotherapy and umbilical chord derived mesenchymal stem cells (MSCs) could improve their condition according to a study reporting ... Read more
Antibodies against Siglec-8 (sialic acid binding immunoglobulin like lectin 8), a protein selectively expressed on certain types of immune system cells is able to inhibit fibrosis in rodent models ... Read more
The European Commission (EC) and the U.S. Food and Drug Administration (FDA) have both designed Ofev (nintedanib; manufactured by Boehringer Ingelheim) an Orphan Drug (ODD) for the treatment of scleroderma, ... Read more
A drug called Buspar (buspirone), which is primarily used to treat generalized anxiety disorder can improve esophageal symptoms in most scleroderma patients with esophageal involvement, according to a study ... Read more